Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vir Biotechnology Inc (NQ: VIR ) 8.600 -0.050 (-0.58%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vir Biotechnology Inc < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Earnings Scheduled For August 9, 2022 August 09, 2022 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. Via Benzinga Brii Biosciences Exercises Option For Vir Biotechnology's Hepatitis B Antibody In Greater China July 05, 2022 Via Benzinga Where Vir Biotechnology Stands With Analysts May 06, 2022 Within the last quarter, Vir Biotechnology (NASDAQ:VIR) has observed the following analyst ratings: Via Benzinga Why HC Wainwright Is Bullish On This Stock's Hepatitis-B Pipeline May 02, 2022 Via Benzinga Vir Biotechnology Earnings Preview August 08, 2022 Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that Vir... Via Benzinga Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate August 04, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Earnings Preview: Vir Biotechnology August 03, 2022 Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Vir... Via Benzinga 7 Undervalued Biotech Stocks to Buy Before They Boom July 25, 2022 Despite recession fears, biological sciences will never go out of style, thus benefitting these undervalued biotech stocks to buy. Via InvestorPlace Why Did FDA Pull Authorization For GSK-Vir's COVID-19 Therapy? Read Here April 06, 2022 Via Benzinga Vir Biotechnology Stock Joins Rank Of Stocks With RS Ratings Over 90 July 11, 2022 On Monday, Vir Biotechnology stock had its Relative Strength (RS) Rating upgraded to 91 Monday, up from 85 a day earlier. Via Investor's Business Daily Is Merck Stock A Buy Amid Reports It Could Buy Seagen For $40 Billion? July 07, 2022 Is Merck stock a buy as reports suggest it could put up $40 billion to acquire Seagen? Is MRK stock a buy right now? Via Investor's Business Daily From Axcella To Tonix, Here Are The Penny Stocks Of Companies Working On Long Covid June 27, 2022 More than four in 10 people in a recent survey knew of someone with long Covid. Via Investor's Business Daily Billionaire Bill Gates Is Betting Against TSLA Stock. Here’s Where He’s Putting His Money Instead. May 25, 2022 Earlier this year, it was revealed that Bill Gates had a half a billion dollar short position against TSLA stock. So, what is he bullish on? Via InvestorPlace HC Wainwright Says This Stock Is Well Capitalized For Value Realization Of Pipeline, Despite COVID-19 Uncertainty May 12, 2022 Via Benzinga 10 Biggest Price Target Changes For Thursday May 12, 2022 Wells Fargo cut the price target on Ford Motor Company (NYSE: F) from $24 to $12. Ford shares fell 2.8% to $12.47 in pre-market trading. Via Benzinga 5 Value Stocks To Watch In The Healthcare Sector May 09, 2022 What Defines a Value Stock? Via Benzinga Earnings Scheduled For May 5, 2022 May 05, 2022 Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million. Via Benzinga Earnings Outlook For Vir Biotechnology May 04, 2022 Vir Biotechnology (NASDAQ:VIR) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to know before the announcement. Analysts estimate that Vir... Via Benzinga 5 Value Stocks In The Healthcare Sector April 25, 2022 What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... Via Benzinga 4 Undervalued Biotech Stocks to Add to Your Buy List April 20, 2022 These biotech stocks have seen their valuations tumble in the year-to-date sell-off. But they have the wherewithal to bounce big and generate decent, market-beating returns. Via InvestorPlace Highly Rated GlaxoSmithKline Eyes Breakout After Racking Up Series Of Wins April 11, 2022 The move comes after the FDA shut down its Vir-partnered Covid antibody, however. Via Investor's Business Daily April Fool April 01, 2022 Today China pushed its iron ore price to an 8 month high to help pay for pricey oil and gas. Via Talk Markets Mid-Afternoon Market Update: Dow Drops 100 Points; Adagio Therapeutics Shares Spike Higher March 30, 2022 U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping 100 points on Wednesday. Via Benzinga 51 Biggest Movers From Yesterday March 31, 2022 Gainers Forge Global Holdings, Inc. (NYSE: FRGE) jumped 73.9% to close at $37.64. Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 60.5% to close at $4.14 on Wednesday... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 30, 2022 Gainers Adagio Therapeutics (NASDAQ:ADGI) shares rose 40.0% to $5.39 during Wednesday's regular session. Trading volume for this security as of 13:31 EST is 80.0... Via Benzinga Mid-Day Market Update: Crude Oil Surges 3%; Revelation Biosciences Shares Plunge March 30, 2022 U.S. stocks traded lower midway through trading following the release of GDP data. Via Benzinga 35 Stocks Moving In Wednesday's Mid-Day Session March 30, 2022 Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares jumped 82.6% to $4.71 after the company reported a year over year increase in Q4 sales results and issued Q1 sales... Via Benzinga Vir Soars As Its Addition To SmallCap 600 Helps Wipe Out Recent Covid Volatility March 30, 2022 Vir Biotechnology remains under pressure despite its looming addition to a new index. Via Investor's Business Daily 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 30, 2022 Gainers Adagio Therapeutics (NASDAQ:ADGI) shares increased by 52.2% to $5.86 during Wednesday's pre-market session. The company's market cap stands at $651.9 million. Via Benzinga 24 Stocks Moving in Wednesday's Pre-Market Session March 30, 2022 Gainers Adagio Therapeutics, Inc. (NASDAQ: ADGI) rose 77.9% to $6.85 in pre-market trading. Adagio Therapeutics said ADG20 (adintrevimab) is the first monoclonal antibody to meet... Via Benzinga < Previous 1 2 ... 6 7 8 9 10 11 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.